2C-B-AN
2C-B-AN is a synthetic psychedelic of the substituted phenethylamine and 2C-x classes. It functions as a prodrug of 2C-B, carrying a modified N-benzyl-type substitution that renders the compound chemically unstable; it converts to 2C-B in the body.1 Its effects are reported to be consistent with other 2C-B variants, producing enhanced coloration, mild visuals, mood lift, and a tingly body sensation. It remains a research chemical with very limited data available.
Contents
Dosage & Duration
Dosage
Duration
Subjective Effects
Effects vary widely by individual, dose, and context.
Physical
The physical effects of 2C-B-AN can be broken down into five components all of which progressively intensify proportional to dosage.
Cognitive
The head space of 2C-B-AN is described by many as one which is both insightful and relatively normal in its thought processes even at moderate to high dosages.
Visual
Enhancements
2C-B-AN presents a full and complete array of possible visual enhancements.
Geometry
The visual geometry that is present throughout this trip can be described as more similar in appearance to that of LSD than that of 2C-E, psilocin, or ayahuasca. They can be comprehensively described as unstructured in their organization, algorithmic in geometric style, intricate in complexity, large in size, fast and smooth in motion, colourful in scheme, glossy in colour, sharp in their edges and angular in their corners. They seem high in algorithmic visuals such as fractals and at higher dosages are significantly more likely to result in states of Level 7A visual geometry over Level 7B.
Hallucinatory States
Like LSD, while 2C-B-AN is capable of producing a full range of low and high level hallucinatory states, this is extremely rare and inconsistent at higher levels but common at lower levels.
Auditory
The auditory effects of 2C-B-AN are more common than some psychedelics in their occurrence and are capable of producing a full range of effects.
by Josie KinsSeptember 2013.Reagent Testing
Loading reagent data
Pharmacology
Pharmacodynamics
Pharmacokinetics
2C-B-AN is chemically unstable and undergoes conversion to 2C-B in vivo, functioning as a prodrug.1 No specific metabolic enzymes or detailed pharmacokinetic parameters have been characterized in the available literature.
Dangerous
Highest riskThese combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Unsafe
AvoidThere is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
Caution
Use cautionThese combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Tolerance
Harm Potential
History & Culture
2C-B-AN first appeared in scientific literature in 2013 when researcher Daniel Trachsel documented the compound, drawing on information from personal communication with P. Rausch dating back to 2009. The substance is a derivative of 2C-B featuring an N-(α′-cyanobenzyl) substitution similar to that…
Legality
By Country
References
Source Pages
Citations
- (May 2020). Prodrugs of New Psychoactive Substances (NPS): A New Challenge. Journal of Forensic Sciences, 65(3), 913–920. https://doi.org/10.1111/1556-4029.14268123456
- (n.d.). Psychoactive Substances Act 2016, section 2 — Meaning of "psychoactive substance". https://www.legislation.gov.uk/ukpga/2016/2/section/21
- (n.d.). The Psychoactive Substances Act 2016 (Commencement) Regulations 2016 (SI 2016/553). https://www.legislation.gov.uk/uksi/2016/553/made1
- (n.d.). Psychoactive Substances Act 2016, section 4 — Producing a psychoactive substance. https://www.legislation.gov.uk/ukpga/2016/2/section/41
- (n.d.). Psychoactive Substances Act 2016, section 5 — Supplying, or offering to supply, a psychoactive substance. https://www.legislation.gov.uk/ukpga/2016/2/section/51
- (n.d.). Psychoactive Substances Act 2016, section 8 — Importing or exporting a psychoactive substance. https://www.legislation.gov.uk/ukpga/2016/2/section/81
Further Reading
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the 2C-B-AN article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.